Literature DB >> 3604926

Enhanced left ventricular systolic performance at high altitude during Operation Everest II.

J Suarez, J K Alexander, C S Houston.   

Abstract

Serial rest and upright cycle exercise 2-dimensional echocardiographic studies were performed in 7 healthy young men during acclimatization to a simulated altitude of 29,000 feet (barometric pressure [PB] 240 torr) in a chamber for 40 days. In all subjects left ventricular (LV) end-diastolic, end-systolic and stroke volumes progressively decreased, with mean reductions of 21%, 40% and 14%, respectively, on ascent to 25,000 feet (PB 282 torr) at rest, and reductions of 23%, 43% and 14% during 60-W exercise. At PB 282 torr, mean arterial blood O2 partial pressures were 37 torr (rest) and 32 torr (exercise), with corresponding O2 saturations of 68% and 59%. All 3 indexes of LV systolic function examined--ejection fraction, ratio of peak systolic pressure to end-systolic volume and mean normalized systolic ejection rate at rest--were sustained in all subjects at high altitude despite reduced preload, pulmonary hypertension and severe hypoxemia. Increases in ejection fraction of 6% at rest and 10% during exercise developed at PB 282 torr and a higher mean normalized systolic ejection rate in association with elevated circulating catecholamines reflecting enhanced sympathetic activity. LV systolic function is not a limiting factor in compromising the exercise capacity of normal humans on ascent to high altitude, even to the peak of Mt. Everest.

Entities:  

Mesh:

Year:  1987        PMID: 3604926     DOI: 10.1016/0002-9149(87)91000-9

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  21 in total

1.  Changes in structure and function of the human left ventricle after acclimatization to high altitude.

Authors:  R Scognamiglio; A Ponchia; G Fasoli; G Miraglia
Journal:  Eur J Appl Physiol Occup Physiol       Date:  1991

Review 2.  Acute mountain sickness. Effects and implications for exercise at intermediate altitudes.

Authors:  E C Pigman
Journal:  Sports Med       Date:  1991-08       Impact factor: 11.136

Review 3.  Red blood cell volume and the capacity for exercise at moderate to high altitude.

Authors:  Robert A Jacobs; Carsten Lundby; Paul Robach; Max Gassmann
Journal:  Sports Med       Date:  2012-08-01       Impact factor: 11.136

Review 4.  The exercising heart at altitude.

Authors:  José A L Calbet; Paul Robach; Carsten Lundby
Journal:  Cell Mol Life Sci       Date:  2009-10-07       Impact factor: 9.261

5.  Left ventricular adaptation to high altitude: speckle tracking echocardiography in lowlanders, healthy highlanders and highlanders with chronic mountain sickness.

Authors:  Chantal Dedobbeleer; Alia Hadefi; Aurelien Pichon; Francisco Villafuerte; Robert Naeije; Philippe Unger
Journal:  Int J Cardiovasc Imaging       Date:  2015-02-10       Impact factor: 2.357

6.  Impaired myocardial function does not explain reduced left ventricular filling and stroke volume at rest or during exercise at high altitude.

Authors:  Mike Stembridge; Philip N Ainslie; Michael G Hughes; Eric J Stöhr; James D Cotter; Michael M Tymko; Trevor A Day; Akke Bakker; Rob Shave
Journal:  J Appl Physiol (1985)       Date:  2015-03-06

7.  The heart and lungs at extreme altitude.

Authors:  J T Reeves; C H Welsh; P D Wagner
Journal:  Thorax       Date:  1994-07       Impact factor: 9.139

8.  High-altitude medicine.

Authors:  Swapnil J Paralikar; Jagdish H Paralikar
Journal:  Indian J Occup Environ Med       Date:  2010-01

Review 9.  Physiology and pathophysiology at high altitude: considerations for the anesthesiologist.

Authors:  Kay B Leissner; Feroze U Mahmood
Journal:  J Anesth       Date:  2009-11-18       Impact factor: 2.078

10.  Impact of acute normobaric hypoxia on regional and global myocardial function: a speckle tracking echocardiography study.

Authors:  Björn Goebel; Veronika Handrick; Alexander Lauten; Michael Fritzenwanger; Juliane Schütze; Sylvia Otto; Hans R Figulla; Thor Edvardsen; Tudor C Poerner; Christian Jung
Journal:  Int J Cardiovasc Imaging       Date:  2012-08-24       Impact factor: 2.357

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.